在瑞士的门诊环境中进行药物遗传测试:使用瑞士索赔数据进行描述性研究
Nina L Wittwer1,2, Christoph R Meier1,2,3, Carola A Huber4
1Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.
Drug safety
|February 20, 2025
概括
瑞士的药物遗传学 (PGx) 测试未得到充分利用,尽管高暴露于PGx药物,但只有0.09%的个人接受了测试. 这突显了个性化药物疗法采用的重大差距.
科学领域:
- 药物基因组学和个性化医学
- 临床药房实践 临床药房实践
- 医疗保健服务研究 医疗服务研究
背景情况:
- 在瑞士,78%的消费者接触到具有药物遗传学 (PGx) 建议的药物.
- 自2017年以来,基本医疗保险覆盖了七种关键药物的预防性PGx测试.
- 门诊PGx测试实施数据以前没有.
研究的目的:
- 为了确定在瑞士的门诊PGx测试的流行率.
- 为了描述接受PGx测试的个体.
- 在PGx测试之前和之后识别药物使用模式.
主要方法:
- 分析来自瑞士一家大型医疗保险公司的索赔数据 (2017-2021年).
- 在瑞士人口中评估PGx测试的流行率.
- 测试个体的人口和临床因素的表征.
主要成果:
- 只有0.09% (844,748人中有817人) 接受了PGx测试.
- 经过PGx测试的个体更经常是女性,并声称使用更多药物,包括PGx药物.
- 药物使用模式在PGx测试前和之后有所不同,最初使用的预防性PGx药物的报销较少.
结论:
- 尽管人们广泛接触PGx药物,但瑞士的PGx测试采用率仍然很低 (0.09%).
- 通过增加PGx测试来改善个性化药疗,存在显著的潜力.
- 需要进一步的研究来了解和克服PGx在门诊环境中的实施障碍.
相关概念视频
Genome-wide Association Studies-GWAS
12.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.3K
Analysis of Population Pharmacokinetic Data
216
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
216
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Genetic Screens
4.8K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
4.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Single Nucleotide Polymorphisms-SNPs
13.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.9K


